These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25111654)
1. The National ALS Registry: a recruitment tool for research. Malek AM; Stickler DE; Antao VC; Horton DK Muscle Nerve; 2014 Nov; 50(5):830-4. PubMed ID: 25111654 [TBL] [Abstract][Full Text] [Related]
2. Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism. Mehta P; Raymond J; Han MK; Larson T; Berry JD; Paganoni S; Mitsumoto H; Bedlack RS; Horton DK J Med Internet Res; 2021 Dec; 23(12):e28021. PubMed ID: 34878988 [TBL] [Abstract][Full Text] [Related]
5. A revision to the United States national ALS registry's algorithm to improve Case-Ascertainment. Mehta P; Raymond J; Han M; Punjani R; Larson T; Berry JD; Brooks BR; Oskarsson B; Goutman SA; Horton K Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):230-236. PubMed ID: 36194072 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015. Raymond J; Oskarsson B; Mehta P; Horton K Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):413-420. PubMed ID: 31131638 [No Abstract] [Full Text] [Related]
8. Recruitment of population-based controls for ALS cases from the National ALS Registry. Bear TM; Malek AM; Foulds A; Rager J; Deperrior SE; Vena JE; Larson TC; Mehta P; Horton DK; Talbott EO Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):395-400. PubMed ID: 33860698 [No Abstract] [Full Text] [Related]
9. A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010-2018. Raymond J; Berry J; Kasarskis EJ; Larson T; Horton DK; Mehta P Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):211-213. PubMed ID: 37789566 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016. Mehta P; Raymond J; Punjani R; Larson T; Bove F; Kaye W; Nelson LM; Topol B; Han M; Muravov O; Genson C; Davis B; Hicks T; Horton K Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):220-225. PubMed ID: 34423697 [No Abstract] [Full Text] [Related]
11. Survival and epidemiology of amyotrophic lateral sclerosis (ALS) cases in the Chicago and Detroit metropolitan cohort: incident cases 2009-2011 and survival through 2018. Punjani R; Larson TC; Wagner L; Davis B; Horton DK; Kaye W Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):203-211. PubMed ID: 36200180 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017. Mehta P; Raymond J; Punjani R; Han M; Larson T; Kaye W; Nelson LM; Topol B; Muravov O; Genson C; Horton DK Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):108-116. PubMed ID: 35422180 [No Abstract] [Full Text] [Related]
14. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016. Mehta P; Raymond J; Punjani R; Larson T; Han M; Bove F; Horton DK Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):378-382. PubMed ID: 35023792 [No Abstract] [Full Text] [Related]
15. Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Schmidt S; Allen KD; Loiacono VT; Norman B; Stanwyck CL; Nord KM; Williams CD; Kasarskis EJ; Kamel F; McGuire V; Nelson LM; Oddone EZ Neuroepidemiology; 2008; 30(3):191-204. PubMed ID: 18421219 [TBL] [Abstract][Full Text] [Related]
16. Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry Swabia. Nagel G; Unal H; Rosenbohm A; Ludolph AC; Rothenbacher D; BMC Neurol; 2013 Feb; 13():22. PubMed ID: 23414001 [TBL] [Abstract][Full Text] [Related]
17. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Wagner L; Rechtman L; Jordan H; Ritsick M; Sanchez M; Sorenson E; Kaye W Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):128-34. PubMed ID: 26399278 [TBL] [Abstract][Full Text] [Related]
18. What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology. Boyce D; Raymond J; Larson TC; Kirkland E; Horton DK; Mehta P Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):615-624. PubMed ID: 38717430 [TBL] [Abstract][Full Text] [Related]
19. The National Registry of Veterans with Amyotrophic Lateral Sclerosis: Department of Veterans Affairs Cooperative Studies Program (CSP) #500a. Kasarkis EJ; Dominic K; Oddone EZ Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():129-32. PubMed ID: 15512895 [TBL] [Abstract][Full Text] [Related]